Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS study

1999305 citationsJournal Article

Authors

Abstract

In this pilot trial, roxithromycin appears to extend the clinical benefit of preventing death and re-infarction for at least 6 months after initial treatment.

Topics & Keywords

Streptococcal Infections and Treatments Reproductive tract infections research Acute Myocardial Infarction Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: European Heart Journal

Volume 20, Issue 2, pp. 121-127

DOI: 10.1053/euhj.1998.1283

Field-Weighted Citation Impact: 53.82